WoundReference improves clinical decisions
 Choose the role that best describes you
Bale S, Tebbie N, Price P, et al.
British journal of nursing (Mark Allen Publishing). Date of publication 2004 Jun 10;volume 13(11):S4-11.
1. Br J Nurs. 2004 Jun 10;13(11):S4-11. A topical metronidazole gel used to treat malodorous wounds. Bale S(1), Tebbie N, Price P. Author information: (1)Nursing Research, University of Wales College of Medicine, Cardiff, Wales, UK. Patients with malodorous wounds often experience social isolation, depression, shame, embarrassment and poor appetite, all of which can have a negative impact on their quality of life. The healthcare professionals caring for them face difficult clinical challenges in terms of treating the cause and managing the symptoms. This study employed a randomized, placebo-controlled double blind design to investigate the effectiveness of metronidazole gel on wound malodour, the main focus of this article. In addition, changes in self-report of mood state were also explored. There was a 100% success rate for the metronidazole gel, mostly within 3 days, with no adverse events reported. As there was a 76% success rate in the placebo group, there was no significant difference in success rates between the two groups. Odour ratings given by patients and nurses were significantly correlated (P<0.001). There was no significant difference in mood state between the groups over time. This study provides some evidence to support the use of metronidazole gel in the treatment of patients with malodorous wounds, but indicates the need for further research in this area. DOI: 10.12968/bjon.2004.13.Sup2.13233 PMID: 15218439 [Indexed for MEDLINE]
Appears in following Topics:
Venous Ulcers - Treatment and Prevention
Pressure Ulcers/Injuries - Treatment
Pressure Ulcers/Injuries - Treatment